WDR17

gene
On this page

Summary

WDR17 (WD repeat domain 17, HGNC:16661) is a protein-coding gene on chromosome 4q34.2, encoding WD repeat-containing protein 17 (Q8IZU2).

This gene encodes a WD repeat-containing protein. It is abundantly expressed in retina and testis, and is thought to be a candidate gene for retinal disease. Alternatively spliced transcript variants have been found for this gene.

Source: NCBI Gene 116966 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 203 total
  • MANE Select transcript: NM_181265

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16661
Approved symbolWDR17
NameWD repeat domain 17
Location4q34.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000150627
Ensembl biotypeprotein_coding
OMIM609005
Entrez116966

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 10 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000280190, ENST00000443118, ENST00000505894, ENST00000507824, ENST00000508596, ENST00000508773, ENST00000509792, ENST00000513261, ENST00000939746, ENST00000939747, ENST00000950580, ENST00000950581, ENST00000950582

RefSeq mRNA: 7 — MANE Select: NM_181265 NM_001350727, NM_001378103, NM_001378104, NM_001378105, NM_001378106, NM_170710, NM_181265

CCDS: CCDS3825, CCDS43284

Canonical transcript exons

ENST00000508596 — 29 exons

ExonStartEnd
ENSE00000995653176177471176177654
ENSE00000995655176172375176172516
ENSE00001081653176162075176162174
ENSE00001081655176163154176163293
ENSE00001081656176159994176160126
ENSE00001081658176160911176161002
ENSE00001081659176177058176177156
ENSE00001081660176156079176156143
ENSE00001295768176150043176150173
ENSE00001297189176151812176151967
ENSE00001297541176135108176135276
ENSE00001299377176148133176148335
ENSE00001301879176131554176131738
ENSE00001302738176141983176142069
ENSE00001311319176150468176150593
ENSE00001315352176149807176149956
ENSE00001315701176125104176125355
ENSE00001319330176145995176146159
ENSE00001322207176128738176128860
ENSE00001322907176139892176139974
ENSE00001384170176115796176115979
ENSE00002061446176168672176168783
ENSE00002066996176065841176066079
ENSE00003499661176173267176173369
ENSE00003571152176174617176174718
ENSE00003617792176119867176120097
ENSE00003636241176111575176111703
ENSE00003791338176137520176137611
ENSE00003908611176179460176182815

Expression profiles

Bgee: expression breadth ubiquitous, 203 present calls, max score 93.09.

FANTOM5 (CAGE): breadth broad, TPM avg 4.0689 / max 150.6209, expressed in 748 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
506972.8114704
506980.7148233
506990.5427183

Top tissues by expression

250 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
endothelial cellCL:000011593.09gold quality
cortical plateUBERON:000534387.32gold quality
prefrontal cortexUBERON:000045184.66gold quality
Brodmann (1909) area 46UBERON:000648383.58gold quality
Brodmann (1909) area 23UBERON:001355483.43gold quality
ventricular zoneUBERON:000305382.94gold quality
frontal cortexUBERON:000187082.68gold quality
neocortexUBERON:000195081.90gold quality
superior frontal gyrusUBERON:000266181.85gold quality
Brodmann (1909) area 9UBERON:001354081.47gold quality
primary visual cortexUBERON:000243681.46gold quality
right hemisphere of cerebellumUBERON:001489081.34gold quality
dorsolateral prefrontal cortexUBERON:000983480.84gold quality
pituitary glandUBERON:000000780.83gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.66gold quality
cerebral cortexUBERON:000095680.50gold quality
cerebellar cortexUBERON:000212980.36gold quality
cerebellar hemisphereUBERON:000224580.33gold quality
right frontal lobeUBERON:000281080.09gold quality
cerebellumUBERON:000203779.98gold quality
occipital lobeUBERON:000202179.91gold quality
caudate nucleusUBERON:000187379.70gold quality
telencephalonUBERON:000189379.70gold quality
nucleus accumbensUBERON:000188279.60gold quality
adenohypophysisUBERON:000219679.53gold quality
ganglionic eminenceUBERON:000402379.49gold quality
forebrainUBERON:000189079.37gold quality
entorhinal cortexUBERON:000272879.34gold quality
brainUBERON:000095579.01gold quality
anterior cingulate cortexUBERON:000983578.74gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.03

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 2)

  • cloning and characterization of gene which represents a new member of the WD repeat family abundant in retina and testis (PMID:12401215)
  • Strong candidate gene for retinitis pigmentosa, RP29 (human 4q32-q34). Conclusion is based on a massive expression data set for mouse (103 strains) and joint analysis of RetNet database. (PMID:19727342)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriowdr17ENSDARG00000075098
mus_musculusWdr17ENSMUSG00000039375
rattus_norvegicusWdr17ENSRNOG00000048847

Paralogs (26): PAFAH1B1 (ENSG00000007168), SNRNP40 (ENSG00000060688), WDR62 (ENSG00000075702), WDR7 (ENSG00000091157), TBL2 (ENSG00000106638), PAK1IP1 (ENSG00000111845), WDR75 (ENSG00000115368), DCAF4 (ENSG00000119599), DAW1 (ENSG00000123977), TEP1 (ENSG00000129566), AHI1 (ENSG00000135541), WDR38 (ENSG00000136918), MAPKBP1 (ENSG00000137802), POC1B (ENSG00000139323), NEDD1 (ENSG00000139350), COP1 (ENSG00000143207), WDR43 (ENSG00000163811), POC1A (ENSG00000164087), WDR88 (ENSG00000166359), WDR81 (ENSG00000167716), DCAF4L2 (ENSG00000176566), DCAF4L1 (ENSG00000182308), WDR27 (ENSG00000184465), NWD1 (ENSG00000188039), WDR5 (ENSG00000196363), WDR5B (ENSG00000196981)

Protein

Protein identifiers

WD repeat-containing protein 17Q8IZU2 (reviewed: Q8IZU2)

All UniProt accessions (5): Q8IZU2, E7ESC9, E9PFA2, H0YAE4, H0YAG1

Isoforms (2)

UniProt IDNamesCanonical?
Q8IZU2-11yes
Q8IZU2-22

RefSeq proteins (7): NP_001337656, NP_001365032, NP_001365033, NP_001365034, NP_001365035, NP_733828, NP_851782* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001680WD40_rptRepeat
IPR011047Quinoprotein_ADH-like_sfHomologous_superfamily
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR019775WD40_repeat_CSConserved_site
IPR020472WD40_PAC1Repeat
IPR036322WD40_repeat_dom_sfHomologous_superfamily

Pfam: PF00400

UniProt features (25 total): repeat 12, sequence variant 6, splice variant 2, sequence conflict 2, chain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IZU2-F185.420.54

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 64 (showing top): RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, chr4q34, WTGAAAT_UNKNOWN, JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, RFX1_01, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, PAX3_TARGET_GENES, MYCMAX_02, MIR607, MIR1277_5P, MIR335_3P, MIR3671

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

1642 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
WDR17LRIT2A6NDA9575
WDR17FMN2Q9NZ56564
WDR17CCDC126Q96EE4542
WDR17ZNF582Q96NG8542
WDR17ASB5Q8WWX0538
WDR17SPCS3P12280537
WDR17ZNF583Q96ND8507
WDR17TLDC2A0PJX2501
WDR17GRIFINA4D1Z8492
WDR17SPATA4Q8NEY3489
WDR17FAM169AQ9Y6X4470
WDR17KCNJ14Q9UNX9459
WDR17GRAMD1CQ8IYS0454
WDR17TMEM205Q6UW68441
WDR17LRIT1Q9P2V4434

IntAct

9 interactions, top by confidence:

ABTypeScore
METNDUFA4psi-mi:“MI:0914”(association)0.420
MAPTSHTN1psi-mi:“MI:0914”(association)0.350
ARL2PTPDC1psi-mi:“MI:0914”(association)0.350
WHAMMP3EXOC5psi-mi:“MI:0914”(association)0.350
ETS1WDR17psi-mi:“MI:0915”(physical association)0.000
RSPH1WDR17psi-mi:“MI:0915”(physical association)0.000

BioGRID (8): WDR17 (Proximity Label-MS), WDR17 (Affinity Capture-MS), WDR17 (Affinity Capture-MS), WDR17 (Affinity Capture-MS), WDR17 (Affinity Capture-MS), WDR17 (Affinity Capture-MS), WDR17 (Two-hybrid), HSPA9 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0JP70, A2CEI4, A5D8Q8, A8Q2R5, A9X1C6, B3MET8, B3NSK1, B4GIJ0, B4HND9, B4J8H6, B4KRQ4, B4MFM2, B4P7H8, B4QB64, O65555, Q13216, Q16MY0, Q1LZ08, Q28YY2, Q3SXM0, Q3U821, Q4KLQ5, Q4QR85, Q566T0, Q567G2, Q58DC2, Q5BIM8, Q5FVP5, Q6DFC6, Q6NPN9, Q6NUD0, Q6P4I2, Q6TEN6, Q6ZJW8, Q6ZJX0, Q7ZVR1, Q8BX17, Q8CFJ9, Q8IZU2, Q8L4M1

Diamond homologs: A1CH75, A1CXL0, A2QI22, A3LQ86, A4R2Q6, A5DL92, A5DST9, A6R3K5, A6S0T8, A6ZPA9, A7ECP3, A7TMF9, A8IR43, B0Y5V6, B2B5V0, B2VZH2, B3RQN1, G0SFB5, O74184, P41318, P61480, Q0CLJ4, Q0UXP3, Q12024, Q1DJF7, Q1JQD2, Q2GXT0, Q2T9T9, Q2UGK1, Q4WP10, Q5APF0, Q5B4R1, Q5BJ90, Q5XI13, Q5XUX1, Q5ZJW8, Q6BLS5, Q6CEW7, Q6CU59, Q6FKK3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

203 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance177
Likely benign9
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

5409 predictions. Top by Δscore:

VariantEffectΔscore
4:176066076:CCAGG:Cdonor_loss1.0000
4:176066077:CAGG:Cdonor_loss1.0000
4:176066080:GTA:Gdonor_loss1.0000
4:176066081:T:Gdonor_loss1.0000
4:176096586:G:GGdonor_gain1.0000
4:176111570:TCAA:Tacceptor_loss1.0000
4:176111571:CAA:Cacceptor_loss1.0000
4:176111572:A:AGacceptor_gain1.0000
4:176111572:AAG:Aacceptor_gain1.0000
4:176111573:A:AGacceptor_gain1.0000
4:176111574:G:GGacceptor_gain1.0000
4:176111574:GGCA:Gacceptor_gain1.0000
4:176111701:CAGGT:Cdonor_loss1.0000
4:176111702:AGGT:Adonor_loss1.0000
4:176111703:GGTAA:Gdonor_loss1.0000
4:176111704:GTA:Gdonor_loss1.0000
4:176111705:T:Adonor_loss1.0000
4:176115794:A:AGacceptor_gain1.0000
4:176115794:AGTT:Aacceptor_gain1.0000
4:176115794:AGTTG:Aacceptor_gain1.0000
4:176115795:G:GGacceptor_gain1.0000
4:176115795:GTTG:Gacceptor_gain1.0000
4:176115795:GTTGG:Gacceptor_gain1.0000
4:176128726:T:TAacceptor_gain1.0000
4:176128736:A:AGacceptor_gain1.0000
4:176128737:G:GGacceptor_gain1.0000
4:176128856:AAAGT:Adonor_gain1.0000
4:176128857:AAGT:Adonor_gain1.0000
4:176128858:AGTGT:Adonor_loss1.0000
4:176128859:GT:Gdonor_gain1.0000

AlphaMissense

8403 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:176142053:T:AW529R1.000
4:176142053:T:CW529R1.000
4:176146006:C:AA538D1.000
4:176146113:T:AW574R1.000
4:176146113:T:CW574R1.000
4:176146143:A:CS584R1.000
4:176146145:T:AS584R1.000
4:176146145:T:GS584R1.000
4:176148146:T:AW594R1.000
4:176148146:T:CW594R1.000
4:176148215:T:AW617R1.000
4:176148215:T:CW617R1.000
4:176115901:A:CS101R0.999
4:176115903:T:AS101R0.999
4:176115903:T:GS101R0.999
4:176125184:T:AW231R0.999
4:176125184:T:CW231R0.999
4:176135126:T:CF397L0.999
4:176135128:T:AF397L0.999
4:176135128:T:GF397L0.999
4:176135198:T:AW421R0.999
4:176135198:T:CW421R0.999
4:176135267:T:AW444R0.999
4:176135267:T:CW444R0.999
4:176139922:T:AW488R0.999
4:176139922:T:CW488R0.999
4:176142055:G:CW529C0.999
4:176142055:G:TW529C0.999
4:176146030:T:AV546D0.999
4:176146033:G:CR547P0.999

dbSNP variants (sampled 300 via entrez): RS10000026 (4:176121709 A>G), RS1000004391 (4:176132987 G>T), RS10000614 (4:176118580 G>A), RS1000077836 (4:176070669 A>C), RS1000083200 (4:176065129 T>C), RS1000098143 (4:176171037 A>G,T), RS10001419 (4:176113462 G>A,T), RS1000144028 (4:176143158 CG>C), RS10001518 (4:176113624 G>T), RS1000165671 (4:176110135 T>C), RS1000172890 (4:176069069 A>G), RS1000217593 (4:176110324 G>A,C), RS1000262548 (4:176151386 G>A,T), RS10003404 (4:176122932 A>G), RS1000346537 (4:176164759 A>G,T)

Disease associations

OMIM: gene MIM:609005 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST005566_27Insomnia7.000000e-07

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, affects expression6
Benzo(a)pyreneaffects methylation, decreases expression, increases methylation, increases mutagenesis4
sodium arsenitedecreases expression, increases abundance2
aristolochic acid Idecreases expression1
FR900359decreases phosphorylation1
trichostatin Aincreases expression1
potassium chromate(VI)increases expression1
CGP 52608affects binding, increases reaction1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
abrinedecreases expression1
dorsomorphinincreases expression, affects cotreatment1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Arsenicdecreases expression, increases abundance1
Clorgylineincreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Vanadatesdecreases expression1
Vincristinedecreases expression1
8-Bromo Cyclic Adenosine Monophosphateincreases expression1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): insomnia